From GlobeNewswire: 2025-03-28 11:05:00

The global prefilled syringe market is projected to reach $15.00 billion by 2030, with a CAGR of 10.6% from 2022 to 2030. The market is driven by the increasing prevalence of chronic diseases and segmented based on type, material, design, application, and distribution channel.

Key players in the market include Gerresheimer AG, Schott Group, Nipro Medical Corporation, BD, Baxter International Inc., Terumo YPSOMED, Weigao group, and B Barun. Trending topics in the market include Injectable Drug Delivery Systems, Biologics, and Home Healthcare.

ANI Pharmaceuticals, FDA, and Pii have made headlines in the prefilled syringes market with FDA approvals and investments in capacity and technology upgrades. The market is expected to grow significantly due to the rising demand for injectable drugs for chronic diseases and the shift towards self-administration.

North America led the market in 2022, with Asia Pacific expected to register the highest CAGR in the prefilled syringes market. The increasing prevalence of chronic diseases and the trend towards self-administration of injectable drugs are driving market growth.

The prefilled syringe market is segmented by type, material, design, application, and region. Disposable prefilled syringes are expected to register a higher CAGR, while plastic prefilled syringes are anticipated to grow significantly during the forecast period.

The prefilled syringes market is witnessing growth due to the uptake of biologics and biosimilars, as well as the need for self-administration of injectable drugs. Patients with chronic diseases prefer convenient and precise drug delivery systems, driving the market’s rapid expansion.



Read more at GlobeNewswire: Prefilled Syringes Market Size to Reach US$ 15.00 Billion